Macrophage ferroptosis in atherosclerosis: unraveling novel antiatherogenic targets and pharmacological strategies
Metabolism and Target Organ Damage · 16.11.2026 · 6 (4)
DOI: 10.20517/mtod.2025.190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 16.11.2026. Verfasst von Jia Shi und 8 weiteren Autor:innen. Die Arbeit nennt 198 Literaturangaben.
Abstract (Originalsprache)
Atherosclerosis is the underlying cause of many cardiovascular diseases, and macrophages play a pivotal role in its intricate landscape, significantly regulating inflammation, lipid metabolism, and iron metabolism. Ferroptosis is an iron-dependent form of regulated cell death driven by lipid peroxidation, and its process is related to macrophage function in atherosclerosis. During atherosclerosis, macrophages contribute to the removal of harmful substances such as lipids and inhibit early development. However, macrophage ferroptosis promotes inflammatory progression, facilitates foam cell and necrotic core formation, promotes calcification, and increases plaque instability. This review first summarizes macrophage heterogeneity in atherosclerosis, then integrates their roles in lipid handling and iron metabolism, and finally focuses on how ferroptosis shapes plaque inflammation, necrotic core formation, calcification, and instability. Currently, the pharmacologic treatment of atherosclerosis is based on lipid-lowering agents, but it remains deficient. Therefore, this review encompasses a variety of potential pharmacological treatments, including organic compounds, natural plant extracts and derivatives, and compound formulations, which can inhibit macrophage ferroptosis and may constitute a novel approach for atherosclerosis treatment. Taken together, this review provides a breakthrough strategy for treating atherosclerosis and establishes a navigational pathway for future therapeutic interventions by targeting macrophage ferroptosis.
Zitieren
APA
Shi, J., Fan, F., Wang, J., Zheng, G., Zhang, R., Guo, L., Zhang, X., Wang, Y., & Ma, C. (2026). Macrophage ferroptosis in atherosclerosis: unraveling novel antiatherogenic targets and pharmacological strategies. Metabolism and Target Organ Damage, 6(4). https://doi.org/10.20517/mtod.2025.190
Vancouver
Shi J, Fan F, Wang J, Zheng G, Zhang R, Guo L, et al. Macrophage ferroptosis in atherosclerosis: unraveling novel antiatherogenic targets and pharmacological strategies. Metabolism and Target Organ Damage. 2026;6(4). doi:10.20517/mtod.2025.190
BibTeX
@article{Shi2026,
author = {Shi, Jia and Fan, Fangyang and Wang, Jida and Zheng, Guobin and Zhang, Runchen and Guo, Liping and Zhang, Xinyu and Wang, Yizhou and Ma, Chuanrui},
title = {Macrophage ferroptosis in atherosclerosis: unraveling novel antiatherogenic targets and pharmacological strategies},
journal = {Metabolism and Target Organ Damage},
year = {2026},
volume = {6},
number = {4},
doi = {10.20517/mtod.2025.190}
}
EUVIMED